Xr Securities LLC Bio N Tech Se Call Options Transaction History

Xr Securities LLC

  • $342 Million
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$126.25 - $231.85 $883,750 - $1.62 Million
-7,000 Closed
0 $0
Q4 2021

Jan 10, 2022
BUY
$216.64 - $362.52 $671,584 - $1.12 Million
3,100 Added 79.49%
7,000 $426,000
Q3 2021

Oct 14, 2021
BUY
$205.93 - $447.23 $329,488 - $715,568
1,600 Added 69.57%
3,900 $418,000
Q2 2021

Jul 26, 2021
BUY
$113.32 - $241.49 $260,635 - $555,427
2,300 New
2,300 $281,000

Others Institutions Holding BNTX

# of Institutions
357
Shares Held
38.3M
Call Options Held
2.45M
Put Options Held
2.29M
View Full List

About BioNTech SE

BNTX Quotes by TradingView
  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $29.3B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email